Arlington Capital Partners Finalizes $3.8 Billion Fund - InforCapital

Arlington Capital Partners, a leading investment firm based in the Washington, D.C. area and focused on sectors regulated by government, has announced the completion of its newest investment fund, Arlington Capital Partners VI (“Fund VI”). With commitments reaching $3.8 billion, Fund VI hit its upper limit, surpassing its initial goal of $3.25 billion and marking it as the firm’s largest fund over its quarter-century operation.

The achievement of Fund VI reflects Arlington’s dedication to its core investment strategy of nurturing and expanding companies that are key players in the aerospace and defense, government services and technology, and healthcare industries. These companies are at the cutting edge of their fields, whether it be in pioneering new technologies for national security, enhancing supply chain robustness, or advancing medical technologies. Their work is vital, offering essential products and services that bolster efficiency, save lives, and cut costs across a wide range of government and commercial sectors.

The managing partners of Arlington—Matt Altman, Michael Lustbader, Peter Manos, and David Wodlinger—shared their thoughts:

“The overwhelming interest in Fund VI underscores our team's exceptional expertise and cooperative methodology, as well as our sustained success in our focused areas which are expected to see significant growth in the coming years. We express our profound gratitude to our investors for their trust in us. We are eager to deploy this capital to become the preferred partner for founders and management teams, guiding them in their journey to become industry leaders and valuable strategic entities.”

With over 150 investments to its name, Arlington has already initiated eight new platform investments and conducted ten additional acquisitions through Fund VI, collaborating with visionary founders and management teams. These ventures range from producing intricate aerospace engine parts and submarine components for the Navy to crafting advanced cyber solutions, biomaterials, therapeutics, and upgrading software for the public sector, addressing a spectrum of crucial demands within regulated industries.

Evercore served as the exclusive global placement agent for Arlington, with Kirkland & Ellis, LLP acting as legal counsel for the fund.